Literature DB >> 30804487

Combined use of ruxolitinib and sirolimus: increased monitoring of triglycerides required.

Tiene Bauters1, Victoria Bordon2, Geneviève Laureys2, Catharina Dhooge2.   

Abstract

Entities:  

Year:  2019        PMID： 30804487     DOI： 10.1038/s41409-019-0488-2

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  3 in total

Review 1.  Etiology and Management of Dyslipidemia in Patients With Cancer.

Authors:  Mikhail de Jesus; Turab Mohammed; Meghana Singh; John G Tiu; Agnes S Kim
Journal:  Front Cardiovasc Med       Date:  2022-04-25

2.  Commentary: Longitudinal changes in circulating metabolites and lipoproteins after breast cancer treatment.

Authors:  Avirup Guha; Nickolas Stabellini; Alberto J Montero
Journal:  Front Cardiovasc Med       Date:  2022-08-09

Review 3.  Haematological Drugs Affecting Lipid Metabolism and Vascular Health.

Authors:  Antonio Parrella; Arcangelo Iannuzzi; Mario Annunziata; Giuseppe Covetti; Raimondo Cavallaro; Emilio Aliberti; Elena Tortori; Gabriella Iannuzzo
Journal:  Biomedicines       Date:  2022-08-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.